Zobrazeno 1 - 10
of 2 735
pro vyhledávání: '"Judson, IR"'
Autor:
Hayes AJ; The Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK. andrew.hayes@rmh.nhs.uk.; The Institute of Cancer Research, London, SM2 5NG, UK. andrew.hayes@rmh.nhs.uk., Nixon IF; Department of Clinical Oncology, The Beatson West of Scotland Cancer Center, Glasgow, G12 0YN, UK., Strauss DC; The Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK., Seddon BM; Department of Medical Oncology, University College London Hospital NHS Foundation Trust, London, NW1 2BU, UK., Desai A; The Midlands Abdominal and Retroperitoneal Sarcoma Unit, Queen Elizabeth Hospital, Birmingham, B15 2WB, UK., Benson C; The Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK., Judson IR; The Institute of Cancer Research, London, SM2 5NG, UK., Dangoor A; Department of Medical Oncology, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, BS1 3NU, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 May 11. Date of Electronic Publication: 2024 May 11.
Autor:
Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Oct 01; Vol. 41 (28), pp. 4453-4454.
Autor:
Woll PJ; University of Sheffield, Sheffield UK and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, UK., Gaunt P; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Gaskell C; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Young R; University of Sheffield, Sheffield UK and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, UK. r.j.young@sheffield.ac.uk., Benson C; Sarcoma Unit, Royal Marsden Hospital, London, UK., Judson IR; Sarcoma Unit, Royal Marsden Hospital, London, UK., Seddon BM; Department of Oncology, University College London Hospital, London, UK., Marples M; St James's University Hospital, Leeds, UK., Ali N; The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK., Strauss SJ; Department of Oncology, University College London Hospital, London, UK., Lee A; The Christie Hospital, Manchester, UK., Hughes A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Kaur B; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Hughes D; University of Sheffield, Sheffield UK and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, UK., Billingham L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Oct; Vol. 129 (9), pp. 1490-1499. Date of Electronic Publication: 2023 Sep 08.
Autor:
Stacchiotti S; Adult Mesenchymal Tumor Medical Oncology Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Fondazione IRCCS, Milan, Italy., Van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Sanfilippo RG; Adult Mesenchymal Tumor Medical Oncology Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Fondazione IRCCS, Milan, Italy., Marreaud SI; Department of Statistics, EORTC - European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Judson IR; The Institute of Cancer Research, London, United Kingdom., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Gelderblom H; Department of Medical Oncology, Leids Universitair Medisch Centrum, Leiden, The Netherlands., Litiere S; Department of Statistics, EORTC - European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Kasper B; Mannheim Cancer Center, Sarcoma Unit, University of Heidelberg, Mannheim University Medical Center, Mannheim, Germany.
Publikováno v:
Cancer [Cancer] 2022 Aug 01; Vol. 128 (15), pp. 2932-2938. Date of Electronic Publication: 2022 May 13.
Autor:
Walls GM; Royal Marsden NHS Foundation Trust, London, U.K.; wallsgerard@gmail.com.; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, U.K., Zaidi SH; Royal Marsden NHS Foundation Trust, London, U.K.; Institute for Cancer Research, London, U.K., Fotiadis N; Royal Marsden NHS Foundation Trust, London, U.K., Jordan S; Royal Marsden NHS Foundation Trust, London, U.K.; Royal Brompton & Harefield Trust, London, U.K., Maruzzo M; Royal Marsden NHS Foundation Trust, London, U.K.; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Hamid I; Royal Marsden NHS Foundation Trust, London, U.K., Al-Muderis O; Royal Marsden NHS Foundation Trust, London, U.K., Khabra K; Royal Marsden NHS Foundation Trust, London, U.K., Benson C; Royal Marsden NHS Foundation Trust, London, U.K.; Institute for Cancer Research, London, U.K., Jones RL; Royal Marsden NHS Foundation Trust, London, U.K.; Institute for Cancer Research, London, U.K., Judson IR; Institute for Cancer Research, London, U.K., Miah AB; Royal Marsden NHS Foundation Trust, London, U.K.; Institute for Cancer Research, London, U.K.
Publikováno v:
Anticancer research [Anticancer Res] 2021 Oct; Vol. 41 (10), pp. 5089-5096.
Autor:
Casali PG; Fondazione IRCCS Istituto Nazionale Tumori, and University of Milan, Milano, Italy; Gustave Roussy, Villejuif, France. Electronic address: paolo.casali@istitutotumori.mi.it., Le Cesne A; Instituto Valenciano De Oncologia, Valencia, Spain., Velasco AP; Adelaide Cancer Centre, Kurralta Park, and Division of Medicine, University of Adelaide, Australia., Kotasek D; Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland., Rutkowski P; Mannheim University Medical Center, Mannheim, Germany., Hohenberger P; Royal Marsden Hospital, London, UK., Fumagalli E; Fondazione IRCCS Istituto Nazionale Tumori, and University of Milan, Milano, Italy; Gustave Roussy, Villejuif, France., Judson IR; Institut Bergonie, Bordeaux, France., Italiano A; Institut Bergonie, Bordeaux, France., Gelderblom H; Leiden University Medical Center, Leiden, Netherlands., Penel N; Centre Oscar Lambret, Lille, France., Hartmann JT; Medizinische Universitätsklinik II, Tübingen, Germany., Duffaud F; Hôpital de La Timone, Aix-Marseille Université, Marseille, France., Goldstein D; Prince of Wales Hospital, Sydney, Australia., Martin-Broto J; Hospital Universitari Son Espases, Palma de Mallorca, Spain., Gronchi A; Fondazione IRCCS Istituto Nazionale Tumori, and University of Milan, Milano, Italy., Wardelmann E; University Hospital Münster, Münster, Germany., Marréaud S; EORTC Headquarters, Brussels, Belgium., Zalcberg JR; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Litière S; EORTC Headquarters, Brussels, Belgium., Blay JY; Department of Medicine, NetSARC and LYRIC, Centre Leon Berard, Lyon, France.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Apr; Vol. 32 (4), pp. 533-541. Date of Electronic Publication: 2021 Jan 19.
Autor:
Craparotta, Ilaria1 (AUTHOR), Mannarino, Laura2,3 (AUTHOR), Zadro, Riccardo2,3 (AUTHOR), Ballabio, Sara4 (AUTHOR), Marchini, Sergio3 (AUTHOR), Pavesi, Giulio5 (AUTHOR), Russo, Marta6 (AUTHOR), Renne, Salvatore Lorenzo2,7 (AUTHOR), Meroni, Marina1 (AUTHOR), Ponzo, Marianna1 (AUTHOR), Bello, Ezia1 (AUTHOR), Sanfilippo, Roberta8 (AUTHOR), Casali, Paolo G.8 (AUTHOR), D'Incalci, Maurizio2,3 (AUTHOR) maurizio.dincalci@hunimed.eu, Frapolli, Roberta1 (AUTHOR)
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 11/26/2024, Vol. 43 Issue 1, p1-14. 14p.
Autor:
Yamada, Yoshiki1,2 (AUTHOR), Wakamatsu, Toru1,2 (AUTHOR) evolutionhhh49@yahoo.co.jp, Imura, Yoshinori1,2 (AUTHOR), Tamiya, Hironari1,2 (AUTHOR), Yagi, Toshinari1 (AUTHOR), Suzuki, Rie1,2 (AUTHOR), Inoue, Akitomo1,2 (AUTHOR), Takami, Haruna1,2 (AUTHOR), Nakai, Sho1,2 (AUTHOR), Outani, Hidetatsu2 (AUTHOR), Kakunaga, Shigeki1,2 (AUTHOR), Takenaka, Satoshi1,2 (AUTHOR)
Publikováno v:
World Journal of Surgical Oncology. 10/5/2024, Vol. 22 Issue 1, p1-9. 9p.
Autor:
Gronchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Bonvalot S; Institute Curie, Paris, France., Poveda Velasco A; Instituto Valenciano De Oncologia, Valencia, Spain., Kotasek D; Adelaide Cancer Centre, Kurralta Park, and Division of Medicine, University of Adelaide, Adelaide, Australia., Rutkowski P; Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland., Hohenberger P; Mannheim University Medical Center, Mannheim, Germany., Fumagalli E; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Judson IR; Royal Marsden Hospital, London, England., Italiano A; Institut Bergonie, Bordeaux, France., Gelderblom HJ; Leiden University Medical Center, Leiden, the Netherlands., van Coevorden F; The Netherland Cancer Institute, Amsterdam, the Netherlands., Penel N; Centre Oscar Lambret, Lille, France., Kopp HG; Medizinische Universitätsklinik II, Tübingen, Germany., Duffaud F; Hôpital La Timone, Aix-Marseille Université, Marseille, France., Goldstein D; Prince of Wales Hospital, Sydney, Australia., Broto JM; Hospital Universitario Viergen del Rocio Sevilla, Seville, Spain., Wardelmann E; University Hospital Münster, Münster, Germany., Marréaud S; EORTC Headquarters, Brussels, Belgium., Smithers M; Princess Alexandra Hospital, The University of Queensland, Brisbane, Australia., Le Cesne A; Institute Gustave Roussy, Villejuif, France., Zaffaroni F; EORTC Headquarters, Brussels, Belgium., Litière S; EORTC Headquarters, Brussels, Belgium., Blay JY; Department of Medicine, NetSARC and LYRIC, Centre Leon Berard, Lyon, France., Casali PG; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy.
Publikováno v:
JAMA surgery [JAMA Surg] 2020 Jun 01; Vol. 155 (6), pp. e200397. Date of Electronic Publication: 2020 Jun 17.
Autor:
van der Graaf WT, Blay, Jy, Chawla, Sp, Kim, Dw, Bui Nguyen, B, Casali, Pg, Schöffski, P, Aglietta, Massimo, Staddon, Ap, Beppu, Y, Le Cesne, A, Gelderblom, H, Judson, Ir, Araki, N, Ouali, M, Marreaud, S, Hodge, R, Dewji, Mr, Coens, C, Demetri, Gd, Fletcher, Cd, Dei Tos AP, Hohenberger, P, EORTC Soft Tissue, Bone Sarcoma Group, PALETTE study group
Publikováno v:
The Lancet (London), 379, 1879-86
The Lancet (London), 379, 9829, pp. 1879-86
Lancet, 379(9829), 1879-1886
The Lancet (London), 379, 9829, pp. 1879-86
Lancet, 379(9829), 1879-1886
Item does not contain fulltext BACKGROUND: Pazopanib, a multitargeted tyrosine kinase inhibitor, has single-agent activity in patients with advanced non-adipocytic soft-tissue sarcoma. We investigated the effect of pazopanib on progression-free survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e504ee0ea9c1bc33830fe09e5cdb03b4
https://www.ncbi.nlm.nih.gov/pubmed/22595799
https://www.ncbi.nlm.nih.gov/pubmed/22595799
